Friday, July 10, 2026

pharma · Hypertension · Breast Neoplasms

Pfizer

Pfizer is a pharma organization headquartered in PARIS, FR. Primary therapeutic focus areas include Hypertension, Breast Neoplasms, Complicated Intra-abdominal Infection, Non-Small Cell Lung Cancer, Arthritis, Rheumatoid

New York 10017, US HQ
103,316 Employees
EMA registrant Type
Company details
Clinical program

Tofacitinib 5 mg BID

Phase 3 · small molecule · Psoriatic Arthritis

Tofacitinib 5 mg BID for Psoriatic Arthritis is a Phase 3 program (small_molecule) at Pfizer with 1 ClinicalTrials.gov record(s).

← All Pfizer projects Phase 3 small molecule completed

Internal code A3921091

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Pfizer
Phase
Phase 3
Modality
small_molecule
Indication
Psoriatic Arthritis
Status
completed
Trials
1